281 related articles for article (PubMed ID: 34217109)
1. Promising therapeutic approaches in pulmonary arterial hypertension.
Ali MK; Ichimura K; Spiekerkoetter E
Curr Opin Pharmacol; 2021 Aug; 59():127-139. PubMed ID: 34217109
[TBL] [Abstract][Full Text] [Related]
2. Novel Treatment Pathways in Pulmonary Arterial Hypertension.
Qaiser KN; Tonelli AR
Methodist Debakey Cardiovasc J; 2021; 17(2):106-114. PubMed ID: 34326930
[TBL] [Abstract][Full Text] [Related]
3. An emerging strategy for targeted therapy of pulmonary arterial hypertension: Vasodilation plus vascular remodeling inhibition.
Hu L; Zhao C; Chen Z; Hu G; Li X; Li Q
Drug Discov Today; 2022 May; 27(5):1457-1463. PubMed ID: 35104622
[TBL] [Abstract][Full Text] [Related]
4. [Novel concepts in the pathobiology of pulmonary arterial hypertension].
Rosenkranz S
Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S167-9. PubMed ID: 18814087
[TBL] [Abstract][Full Text] [Related]
5. The treatment strategy of connective tissue disease associated pulmonary arterial hypertension: Evolving into the future.
Zhao J; Wang Q; Deng X; Qian J; Tian Z; Liu Y; Li M; Zeng X
Pharmacol Ther; 2022 Nov; 239():108192. PubMed ID: 35461923
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory Mechanisms in the Pathogenesis of Pulmonary Arterial Hypertension: Recent Advances.
Mercurio V; Cuomo A; Naranjo M; Hassoun PM
Compr Physiol; 2021 Apr; 11(2):1805-1829. PubMed ID: 33792903
[TBL] [Abstract][Full Text] [Related]
7. Novel Mechanisms Targeted by Drug Trials in Pulmonary Arterial Hypertension.
Condon DF; Agarwal S; Chakraborty A; Auer N; Vazquez R; Patel H; Zamanian RT; de Jesus Perez VA
Chest; 2022 Apr; 161(4):1060-1072. PubMed ID: 34655569
[TBL] [Abstract][Full Text] [Related]
8. New Drugs and Therapies in Pulmonary Arterial Hypertension.
Shah AJ; Beckmann T; Vorla M; Kalra DK
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982922
[TBL] [Abstract][Full Text] [Related]
9. BMP type II receptor as a therapeutic target in pulmonary arterial hypertension.
Orriols M; Gomez-Puerto MC; Ten Dijke P
Cell Mol Life Sci; 2017 Aug; 74(16):2979-2995. PubMed ID: 28447104
[TBL] [Abstract][Full Text] [Related]
10. Role of macrophages in pulmonary arterial hypertension.
Zhang MQ; Wang CC; Pang XB; Shi JZ; Li HR; Xie XM; Wang Z; Zhang HD; Zhou YF; Chen JW; Han ZY; Zhao LL; He YY
Front Immunol; 2023; 14():1152881. PubMed ID: 37153557
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Src activation reverses pulmonary vascular remodeling in experimental pulmonary arterial hypertension via Akt/mTOR/HIF-1 signaling pathway.
Liu P; Gu Y; Luo J; Ye P; Zheng Y; Yu W; Chen S
Exp Cell Res; 2019 Jul; 380(1):36-46. PubMed ID: 30802452
[TBL] [Abstract][Full Text] [Related]
12. FOXM1 promotes pulmonary artery smooth muscle cell expansion in pulmonary arterial hypertension.
Bourgeois A; Lambert C; Habbout K; Ranchoux B; Paquet-Marceau S; Trinh I; Breuils-Bonnet S; Paradis R; Nadeau V; Paulin R; Provencher S; Bonnet S; Boucherat O
J Mol Med (Berl); 2018 Feb; 96(2):223-235. PubMed ID: 29290032
[TBL] [Abstract][Full Text] [Related]
13. Novel Pharmacological Targets for Pulmonary Arterial Hypertension.
Klinger JR
Compr Physiol; 2021 Sep; 11(4):2297-2349. PubMed ID: 34558669
[TBL] [Abstract][Full Text] [Related]
14. Novel Advances in Modifying BMPR2 Signaling in PAH.
Dannewitz Prosseda S; Ali MK; Spiekerkoetter E
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374819
[TBL] [Abstract][Full Text] [Related]
15. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary artery banding is a relevant model to study the right ventricular remodeling and dysfunction that occurs in pulmonary arterial hypertension.
Akazawa Y; Okumura K; Ishii R; Slorach C; Hui W; Ide H; Honjo O; Sun M; Kabir G; Connelly K; Friedberg MK
J Appl Physiol (1985); 2020 Aug; 129(2):238-246. PubMed ID: 32644912
[TBL] [Abstract][Full Text] [Related]
17. Looking to the future: a new decade of pulmonary arterial hypertension therapy.
McLaughlin VV
Eur Respir Rev; 2011 Dec; 20(122):262-9. PubMed ID: 22130819
[TBL] [Abstract][Full Text] [Related]
18. Ultrastructural Changes of the Right Ventricular Myocytes in Pulmonary Arterial Hypertension.
Shults NV; Kanovka SS; Ten Eyck JE; Rybka V; Suzuki YJ
J Am Heart Assoc; 2019 Mar; 8(5):e011227. PubMed ID: 30807241
[TBL] [Abstract][Full Text] [Related]
19. [The cancer paradigm in pulmonary arterial hypertension: towards anti-remodeling therapies targeting metabolic dysfunction?].
Dumas SJ; Humbert M; Cohen-Kaminsky S
Biol Aujourdhui; 2016; 210(4):171-189. PubMed ID: 28327277
[TBL] [Abstract][Full Text] [Related]
20. Focus on Early Events: Pathogenesis of Pulmonary Arterial Hypertension Development.
Rafikova O; Al Ghouleh I; Rafikov R
Antioxid Redox Signal; 2019 Nov; 31(13):933-953. PubMed ID: 31169021
[No Abstract] [Full Text] [Related]
[Next] [New Search]
